openPR Logo
Press release

Global Primary Sclerosing Cholangitis Market

06-13-2019 02:11 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Primary Sclerosing Cholangitis Market

Global Primary Sclerosing Cholangitis Market

The Primary Sclerosing Cholangitis report offers insights into vital aspects like growth,CAGR value, market share and revenue analysis. It evaluates the growth opportunities, threats, market drivers and risks involved. understand the market competition by analyzing the top vendors, with their market profile, revenue, profits, import-export details, and market share. it states the pricing structure, import-export details, supply chain analysis, SWOT analysis to facilitate the key decision-making process. This report helps to understand the data sources, implied research methodology and vital conclusions.

The Primary Sclerosing Cholangitis report presents all the necessary data required to form resulting yielding business strategies for industry analyst, experts and professional to decide their business strategies. A business outline, market share, offering, benefits, and methodologies of top players are incorporated. The report is a key source for gaining the marketing research which will exponentially speed up your business.

Market Analysis:

Global Primary Sclerosing Cholangitis Market is expected to rise gradually to an estimated value of USD 157.13 million by 2026, registering a CAGR of 3.7% in the forecast period of 2019-2026 with the annual sales of USD 117.5 million in the year of 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Ask For Complimentary Sample PDF | Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-primary-sclerosing-cholangitis-market

Key Market Competitors:

Global Primary Sclerosing Cholangitis Market
Few of the major competitors currently working in the primary sclerosing cholangitis market are Acorda Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), NGM Biopharmaceuticals (US), Intercept Pharmaceuticals, Inc. (US), Dr. Falk Pharma GmbH (Germany), ALLERGAN (Ireland), Takeda Pharmaceutical Company Limited. (Japan), DURECT CORPORATION (US), Conatus Pharmaceuticals, Inc. (US), Sirnaomics, Inc. (US), and HighTide Therapeutics Inc. (China), Glenmark (India), Impax Laboratories, LLC (US), Mylan N.V. (US), Teva Pharmaceuticals Industries Ltd. (Israel) and few among others.

Market Drivers

Rise in incidence and prevalence rate of liver failure and bile cancer associated with PSC.
Large No. of pipeline molecules is expected to drive the growth of the market.

Market Restraints

Withdrawal of novel molecules from late stage clinical trials will restrain the growth of the market.
Organ transplantation remains the alternative which is associated with many risk factors like relapse of the disease.
Lack of skilled expertise in remote areas
Fewer Government initiatives taken in this direction.

Table of Contents

Introduction
1.Market Segmentation
2.Market Overview
3.Executive Summary
4.Premium Insights
5.Global, By Component
6.Product Type
7.Delivery
8.Industry Type
9.Geography

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-primary-sclerosing-cholangitis-market

Segmentation:

By Type
Classic PSC
Small-duct PSC
PSC associated with autoimmune hepatitis
By Treatment Type
Ursodeoxycholic acid
Obeticholic Acid
Methotrexate
Corticosteroids
Others
By Symptom Control
Antihistamines
Cholestyramine
Antibacterials
Opioid Antagonists
Colestipol
Others
By End- User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America
US.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Key Developments in the Market:

On 19th January, 2016, Acorda Therapeutics, Inc. announced that it entered into an agreement to acquire Biotie Therapies Corp. According to the agreement, the company will acquire the four pipeline products that include BTT1023, a fully human monoclonal antibody in Phase 2 development for treatment of primary sclerosing cholangitis (PSC) which will help company to grow.
On 27th March, 2019, Gilead Sciences, Inc. announced the company’s research and development programs in primary sclerosing cholangitis (PSC) will be presented at The International Liver Congress™ 2019 in Vienna. Currently the novel molecule, Cilofexor has not get the approval but once it gets approval it will generate the revenue for the company and contribute towards the growth of the market.

Competitive Analysis:

Global primary sclerosing cholangitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of primary sclerosing cholangitis market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Inquiry For Customize Report With Discount at : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-primary-sclerosing-cholangitis-market

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

About Us:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Primary Sclerosing Cholangitis Market here

News-ID: 1774598 • Views: 1613

More Releases from Data Bridge Market Research

Functional Beverages Market, Industry Size, Segmentation, Application Analysis, …
Market Analysis Insights: Functional Beverages Market  The functional beverages market is expected to witness market growth at a rate of 7.3% in the forecast period of 2022 to 2029. Data Bridge Market Research report on functional beverages market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The growth in awareness globally is escalating the growth
Shea Butter Market, Industry Size, Segmentation, Application Analysis, Trends, & …
Market Analysis & Insights: Shea Butter Market  The Shea butter market is expected to witness market growth at a rate of 12.80% in the forecast period of 2022 to 2029. Data Bridge Market Research report on Shea butter market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The changing food industry landscape is escalating the
Bone Grafts and Substitutes Market Incredible Possibilities, Growth with Industr …
Bone Grafts and Substitutes Market report is sure to lend a hand in enhancing sales and improving return on investment (ROI). This market report comprises of a chapter on the global market and all of its associated companies with their profiles, which gives important information and data pertaining to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies. As today's businesses greatly demand the
Europe Smart Facial Cleansing Devices Market is set to Witness Huge Demand at a …
Europe smart facial cleansing devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 11.3% in the forecast period of 2021 to 2028 and is expected to reach USD 469,240.13 thousand by 2028. A few of the most important objectives of the world class Europe Smart Facial Cleansing Devices report include;

All 5 Releases


More Releases for Primary

Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Primary Lithium Battery (Primary Lithium Batteries) Industry Analysis by 2025:  …
In its recently published report, QY Research has provided unique insights about global Primary Lithium Battery (Primary Lithium Batteries) market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Primary
Primary Cells And Primary Batteries Market Analysis by Production Capacity, Dyna …
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Primary Cells And Primary Batteries market. Description The Global Primary Cells And Primary Batteries Market report offers a comprehensive evaluation of the Global Primary Cells And Primary Batteries industry. This report evaluates the Global market for " Global Primary Cells And Primary Batteries". The Global Primary Cells
Primary Immunodeficiency Diseases Market: Key Insights
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market. These companies have been
01-25-2017 | Health & Medicine
TMR
Global Primary Biliary Cholangitis Treatment Market is Driven by Rise in Inciden …
Primary biliary cholangitis, previously known as primary biliary cirrhosis, is a rare chronic liver disease, primarily characterized by destruction of the bile ducts which transport bile acid out of the liver. Although the primary cause of the disease has not yet been elucidated, research across the world has attributed it to be autoimmune in nature. The progress of this disease results in the harmful accumulation of bile acid, which causes
Primary Packaging Market is driven With Demand for Primary Packaging Products fr …
Primary packaging is the layer of packaging which is in immediate contact with the product or it is the first packaging layer in which the product is enclosed. Primary packaging has diverse range of applications and functions, depending on the type product, mode of transport and storage facilities. The most important function of primary packaging is to protect and preserve the product from external damage, contamination and spoiling. Primary packaging